Interpretation of Laboratory Values
This patient has mild leukocytosis with absolute eosinophilia (0.8 × 10⁹/L), and the most likely causes depend critically on travel history, medication exposure, and atopic conditions—with helminth infection, allergic disease, and drug reactions being the primary considerations in descending order of clinical importance.
Understanding the Blood Count
The presented values show:
- WBC 11.3 × 10⁹/L: Mild leukocytosis (upper limit of normal ~11.0)
- Absolute eosinophils 0.8 × 10⁹/L: This represents eosinophilia, defined as >0.5 × 10⁹/L 1
- Absolute neutrophils 7.8 × 10⁹/L: Mild neutrophilia
- Lymphocytes 17.7%: Relative lymphopenia (likely due to neutrophil predominance)
The eosinophil count of 0.8 × 10⁹/L is significant and warrants investigation, though it falls below the hypereosinophilia threshold of ≥1.5 × 10⁹/L 1.
Most Likely Causes Based on Clinical Context
In Travelers or Migrants
Helminth (parasitic worm) infection is the single most common identifiable cause of eosinophilia in returning travelers and migrants, with diagnosis rates of 19-80% 1. Key parasites include:
- Strongyloides stercoralis (critical to identify—can cause fatal hyperinfection in immunocompromised patients) 1
- Schistosoma species (associated with long-term bladder cancer risk) 1
- Hookworm, Ascaris, Toxocara
- Filarial infections (particularly if travel to West Africa) 1
In Non-Travelers
Allergic conditions and drug reactions are the most common causes in populations without endemic helminth exposure 1. Specifically:
- Atopic disease: Asthma, eczema, allergic rhinitis 1
- Medications: Many drugs can cause eosinophilia 1
- Fungal allergy: Accounts for 21% of eosinophilia cases in secondary care 2
Other Important Considerations
The mild neutrophilia (7.8 × 10⁹/L) alongside eosinophilia suggests:
- Acute parasitic infection (particularly Katayama syndrome from acute schistosomiasis, which presents with fever, eosinophilia, and systemic symptoms 2-8 weeks post-freshwater exposure) 1
- Concurrent bacterial infection or inflammatory process
- Medication effect or stress response (can elevate both cell types) 3
Critical Red Flags to Assess
Immediate evaluation needed if:
- Symptoms of end-organ damage (cardiac, pulmonary, neurologic) 1
- Fever with rash and recent freshwater exposure (suggests Katayama syndrome) 1
- Rapid progression of eosinophil count 4
Diagnostic Approach
Essential History Elements
- Travel history: Any travel to endemic areas (Africa, Asia, Latin America, Caribbean)
- Freshwater exposure: Swimming in lakes/rivers 2-8 weeks prior
- Medication review: All current and recent medications
- Atopic history: Asthma, eczema, allergic rhinitis
- Symptoms: GI (diarrhea, abdominal pain), respiratory (cough, wheeze), skin (rash, urticaria), constitutional (fever, weight loss)
First-Line Investigations
For asymptomatic eosinophilia with travel/migration history 1:
- Strongyloides serology (critical—high sensitivity)
- Schistosoma serology
- Stool microscopy (concentrated, multiple samples)
- Stool PCR for helminths
- Filarial serology (if West Africa exposure)
For non-travelers 1:
- Review medications and discontinue potential culprits
- Assess for atopic disease
- Consider IgE level (if ≥1000 IU/L, 91% have fungal allergy or parasitic infection) 2
Management Considerations
If eosinophilia persists ≥1.5 × 10⁹/L for >3 months without identified cause, refer to hematology to exclude hypereosinophilic syndrome or malignancy 1.
For asymptomatic eosinophilia with negative initial workup in travelers/migrants, empirical treatment with albendazole 400 mg single dose plus ivermectin 200 μg/kg single dose is recommended (excludes Loa loa endemic areas before ivermectin) 1.
Common Pitfalls
- Assuming allergy alone explains eosinophilia without excluding parasitic infection in travelers
- Missing Strongyloides infection (can be fatal if patient becomes immunosuppressed)
- Not recognizing that normal stool microscopy doesn't exclude helminth infection (serology more sensitive)
- Overlooking medication-induced eosinophilia